{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:54Z","timestamp":1787003634554,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2023-04283"],"award-info":[{"award-number":["2023-04283"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2016-05964"],"award-info":[{"award-number":["2016-05964"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer Society of Manitoba Graduate Student Fellowship"},{"name":"McCrorie-West Fellowship in Alzheimer\u2019s Research","award":["44172"],"award-info":[{"award-number":["44172"]}]},{"name":"Baxter Bursary"},{"name":"University of Manitoba Tri-Agency Bridge Funding","award":["57289"],"award-info":[{"award-number":["57289"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02039-2","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:13:10Z","timestamp":1747465990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Brain metabolic imaging-based model identifies cognitive stability in prodromal Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Jarrad","family":"Perron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Scramstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"2039_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.14283\/jpad.2023.63","volume":"11","author":"Y Cui","year":"2024","unstructured":"Cui, Y., Yang, W., Shuai, J., Ma, Y. & Yan, Y. Lifestyle and socioeconomic transition and health consequences of Alzheimer\u2019s disease and other dementias in global, from 1990 to 2019. J. Prev. Alzheimers Dis. 11, 88\u201396. https:\/\/doi.org\/10.14283\/jpad.2023.63 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"2039_CR2","doi-asserted-by":"publisher","unstructured":"Nandi, A. et al. Cost of care for Alzheimer\u2019s disease and related dementias in the united States: 2016 to 2060. Npj Aging. 10 https:\/\/doi.org\/10.1038\/s41514-024-00136-6 (2024).","DOI":"10.1038\/s41514-024-00136-6"},{"key":"2039_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer, R., Johnson, E., Ziegler-Graham, K. & Arrighi, H. M. Forecasting the global burden of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 3, 186\u2013191. https:\/\/doi.org\/10.1016\/j.jalz.2007.04.381 (2007).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2039_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859","author":"CR Jack","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.13859 (2024).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2039_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault, J. et al. Biomarker-based staging of alzheimer disease: rationale and clinical applications. Nat. Reviews Neurol. 20, 232\u2013244. https:\/\/doi.org\/10.1038\/s41582-024-00942-2 (2024).","journal-title":"Nat. Reviews Neurol."},{"key":"2039_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis, Z., Shah, R. C. & Bennett, D. A. Diagnosis and management of dementia: review. JAMA: J. Am. Med. Association. 322, 1589\u20131599. https:\/\/doi.org\/10.1001\/jama.2019.4782 (2019).","journal-title":"JAMA: J. Am. Med. Association"},{"key":"2039_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/bmj.p1580","volume":"382","author":"E Mahase","year":"2023","unstructured":"Mahase, E. Alzheimer\u2019s disease: Lecanemab gets full FDA approval and black box safety warning. BMJ (Online). 382, 1580\u20131580. https:\/\/doi.org\/10.1136\/bmj.p1580 (2023).","journal-title":"BMJ (Online)"},{"key":"2039_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jama.2023.11704","volume":"330","author":"JJ Manly","year":"2023","unstructured":"Manly, J. J. & Deters, K. D. Donanemab for alzheimer Disease\u2014Who benefits and who is harmed?? JAMA 330, 510. https:\/\/doi.org\/10.1001\/jama.2023.11704 (2023).","journal-title":"JAMA"},{"key":"2039_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2039_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/WNL.0000000000207438","volume":"101","author":"DS Knopman","year":"2023","unstructured":"Knopman, D. S. & Hershey, L. Implications of the approval of Lecanemab for alzheimer disease patient care: incremental step or paradigm shift?? Neurology 101, 610\u2013620. https:\/\/doi.org\/10.1212\/WNL.0000000000207438 (2023).","journal-title":"Neurology"},{"key":"2039_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in early symptomatic alzheimer disease. JAMA 330, 512. https:\/\/doi.org\/10.1001\/jama.2023.13239 (2023).","journal-title":"JAMA"},{"key":"2039_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.14283\/jpad.2021.41","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings, J. et al. Aducanumab: appropriate use recommendations. J. Prev. Alzheimer\u2019s Disease. 8, 398\u2013410. https:\/\/doi.org\/10.14283\/jpad.2021.41 (2021).","journal-title":"J. Prev. Alzheimer\u2019s Disease"},{"key":"2039_CR13","doi-asserted-by":"publisher","first-page":"fcad175","DOI":"10.1093\/braincomms\/fcad175","volume":"5","author":"KY Liu","year":"2023","unstructured":"Liu, K. Y. et al. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer\u2019s disease. Brain Commun. 5, fcad175. https:\/\/doi.org\/10.1093\/braincomms\/fcad175 (2023).","journal-title":"Brain Commun."},{"key":"2039_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-231198","volume":"97","author":"LA Digma","year":"2024","unstructured":"Digma, L. A., Winer, J. R. & Greicius, M. D. Substantial doubt remains about the efficacy of Anti-Amyloid antibodies. J. Alzheimers Dis. 97, 567\u2013572. https:\/\/doi.org\/10.3233\/JAD-231198 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"2039_CR15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s10072-023-07194-w","volume":"45","author":"JM Dantas","year":"2024","unstructured":"Dantas, J. M. et al. Efficacy of anti-amyloid-\u00df monoclonal antibody therapy in early Alzheimer\u2019s disease: a systematic review and meta-analysis. Neurol. Sci. 45, 2461\u20132469. https:\/\/doi.org\/10.1007\/s10072-023-07194-w (2024).","journal-title":"Neurol. Sci."},{"key":"2039_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.14283\/jpad.2024.37","volume":"11","author":"AC Bradshaw","year":"2024","unstructured":"Bradshaw, A. C. & Georges, J. Anti-Amyloid therapies for alzheimer\u2019s disease: an alzheimer Europe position paper and call to action. J. Prev. Alzheimers Dis. 11, 265\u2013273. https:\/\/doi.org\/10.14283\/jpad.2024.37 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"2039_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach, T. G., Monsell, S. E., Phillips, L. E. & Kukull, W. Accuracy of the clinical diagnosis of alzheimer disease at National Institute on aging alzheimer disease centers, 2005\u20132010. J. Neuropathol. Exp. Neurol. 71, 266\u2013273. https:\/\/doi.org\/10.1097\/NEN.0b013e31824b211b (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2039_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/JGP.0b013e3181a6516e","volume":"17","author":"HMD Brunnstr\u00f6m","year":"2009","unstructured":"Brunnstr\u00f6m, H. M. D. & Englund, E. M. D. P. D. Clinicopathological concordance in dementia diagnostics. Am. J. Geriatric Psychiatry. 17, 664\u2013670. https:\/\/doi.org\/10.1097\/JGP.0b013e3181a6516e (2009).","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"2039_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jalz.2011.04.011","volume":"7","author":"P Scheltens","year":"2011","unstructured":"Scheltens, P. & Rockwood, K. How golden is the gold standard of neuropathology in dementia? Alzheimer\u2019s Dement. 7, 486\u2013489. https:\/\/doi.org\/10.1016\/j.jalz.2011.04.011 (2011).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2039_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cger.2018.06.005","volume":"34","author":"EGMD Tangalos","year":"2018","unstructured":"Tangalos, E. G. M. D. & Petersen, R. C. M. D. P. Mild cognitive impairment in geriatrics. Clin. Geriatr. Med. 34, 563\u2013589. https:\/\/doi.org\/10.1016\/j.cger.2018.06.005 (2018).","journal-title":"Clin. Geriatr. Med."},{"key":"2039_CR21","doi-asserted-by":"publisher","first-page":"e12272","DOI":"10.1002\/trc2.12272","volume":"8","author":"P Thaipisuttikul","year":"2022","unstructured":"Thaipisuttikul, P., Jaikla, K., Satthong, S. & Wisajun, P. Rate of conversion from mild cognitive impairment to dementia in a Thai hospital-based population: A retrospective cohort. Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions. 8, e12272. https:\/\/doi.org\/10.1002\/trc2.12272 (2022).","journal-title":"Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions"},{"key":"2039_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000354370","volume":"3","author":"A Ward","year":"2013","unstructured":"Ward, A., Tardiff, S., Dye, C. & Arrighi, H. M. Rate of conversion from prodromal Alzheimer\u2019s disease to Alzheimer\u2019s dementia: A systematic review of the literature. Dement. Geriatric Cogn. Disorders Extra. 3, 320\u2013332. https:\/\/doi.org\/10.1159\/000354370 (2013).","journal-title":"Dement. Geriatric Cogn. Disorders Extra"},{"key":"2039_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13195-019-0480-5","volume":"11","author":"H Shimada","year":"2019","unstructured":"Shimada, H., Doi, T., Lee, S. & Makizako, H. Reversible predictors of reversion from mild cognitive impairment to normal cognition: a 4-year longitudinal study. Alzheimers Res. Ther. 11, 24\u201324. https:\/\/doi.org\/10.1186\/s13195-019-0480-5 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"2039_CR24","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.3390\/app122211463","volume":"12","author":"J Perron","year":"2022","unstructured":"Perron, J. & H Ko, J. Review of quantitative methods for the detection of Alzheimer\u2019s disease with positron emission tomography. Appl. Sci. 12, 11463. https:\/\/doi.org\/10.3390\/app122211463 (2022).","journal-title":"Appl. Sci."},{"key":"2039_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01004-3","author":"N Villain","year":"2024","unstructured":"Villain, N. & Planche, V. Disentangling clinical and biological trajectories of neurodegenerative diseases. Nat. Reviews Neurol. https:\/\/doi.org\/10.1038\/s41582-024-01004-3 (2024).","journal-title":"Nat. Reviews Neurol."},{"key":"2039_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3233\/JAD-230633","volume":"96","author":"J Perron","year":"2023","unstructured":"Perron, J., Scramstad, C. & Ko, J. H. Analysis of costs for Imaging-Assisted pharmaceutical intervention in Alzheimer\u2019s disease with Lecanemab: snapshot of the first 3 years. J. Alzheimers Dis. 96, 1305\u20131315. https:\/\/doi.org\/10.3233\/JAD-230633 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"2039_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2967\/jnumed.122.265314","volume":"64","author":"MM Graham","year":"2023","unstructured":"Graham, M. M. The future of nuclear medicine in the united States. J. Nucl. Med. 64, 1352\u20131353. https:\/\/doi.org\/10.2967\/jnumed.122.265314 (2023).","journal-title":"J. Nucl. Med."},{"key":"2039_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00259-023-06177-5","volume":"50","author":"A Verger","year":"2023","unstructured":"Verger, A. et al. FDA approval of Lecanemab: the real start of widespread amyloid PET use? \u2014 the EANM neuroimaging committee perspective. Eur. J. Nucl. Med. Mol. Imaging. 50, 1553\u20131555. https:\/\/doi.org\/10.1007\/s00259-023-06177-5 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2039_CR29","doi-asserted-by":"publisher","unstructured":"Juengling, F. et al. PET imaging in dementia: Mini-Review and Canadian perspective for clinical use. Can. J. Neurol. Sci. 1\u201313. https:\/\/doi.org\/10.1017\/cjn.2024.31 (2024).","DOI":"10.1017\/cjn.2024.31"},{"key":"2039_CR30","doi-asserted-by":"publisher","unstructured":"Zukotynski, K. et al. PET\/CT of Dementia. Am. J. Roentgenol. 211, 246\u2013259. https:\/\/doi.org\/10.2214\/AJR.18.19822 (2018).","DOI":"10.2214\/AJR.18.19822"},{"key":"2039_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.semnuclmed.2021.01.002","volume":"51","author":"S Minoshima","year":"2021","unstructured":"Minoshima, S., Mosci, K., Cross, D. & Thientunyakit, T. Brain [F-18]FDG PET for clinical dementia workup: differential diagnosis of Alzheimer\u2019s disease and other types of dementing disorders. Semin. Nucl. Med. 51, 230\u2013240. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.01.002 (2021).","journal-title":"Semin. Nucl. Med."},{"key":"2039_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.nicl.2018.03.007","volume":"18","author":"K Popuri","year":"2018","unstructured":"Popuri, K. et al. Development and validation of a novel dementia of Alzheimer\u2019s type (DAT) score based on metabolism FDG-PET imaging. NeuroImage Clin. 18, 802\u2013813. https:\/\/doi.org\/10.1016\/j.nicl.2018.03.007 (2018).","journal-title":"NeuroImage Clin."},{"key":"2039_CR33","doi-asserted-by":"publisher","first-page":"13236","DOI":"10.1038\/s41598-018-31653-6","volume":"8","author":"A Katako","year":"2018","unstructured":"Katako, A. et al. Machine learning identified an Alzheimer\u2019s disease-related FDG-PET pattern which is also expressed in lewy body dementia and Parkinson\u2019s disease dementia. Sci. Rep. 8, 13236\u201313213. https:\/\/doi.org\/10.1038\/s41598-018-31653-6 (2018).","journal-title":"Sci. Rep."},{"key":"2039_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hbm.24783","volume":"41","author":"E Yee","year":"2020","unstructured":"Yee, E., Popuri, K. & Beg, M. F. Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer\u2019s dementia score. Hum. Brain. Mapp. 41, 5\u201316. https:\/\/doi.org\/10.1002\/hbm.24783 (2020).","journal-title":"Hum. Brain. Mapp."},{"key":"2039_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1109\/TMI.2020.3022591","volume":"40","author":"X Pan","year":"2021","unstructured":"Pan, X. et al. Multi-View separable pyramid network for AD prediction at MCI stage by 18 F-FDG brain PET imaging. IEEE Trans. Med. Imaging. 40, 81\u201392. https:\/\/doi.org\/10.1109\/TMI.2020.3022591 (2021).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"2039_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JAD-201591","volume":"80","author":"D Ma","year":"2021","unstructured":"Ma, D. et al. Blinded clinical evaluation for dementia of Alzheimer\u2019s type classification using FDG-PET: A comparison between Feature-Engineered and Non-Feature-Engineered machine learning methods. J. Alzheimers Dis. 80, 715\u2013726. https:\/\/doi.org\/10.3233\/JAD-201591 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"2039_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.media.2018.02.002","volume":"46","author":"D Lu","year":"2018","unstructured":"Lu, D., Popuri, K., Ding, G. W., Balachandar, R. & Beg, M. F. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer\u2019s disease. Med. Image. Anal. 46, 26\u201334. https:\/\/doi.org\/10.1016\/j.media.2018.02.002 (2018).","journal-title":"Med. Image. Anal."},{"key":"2039_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13195-024-01535-3","volume":"16","author":"S Heyer","year":"2024","unstructured":"Heyer, S. et al. F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis. Alzheimers Res. Ther. 16, 182. https:\/\/doi.org\/10.1186\/s13195-024-01535-3 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"2039_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","volume":"11","author":"YN Ou","year":"2019","unstructured":"Ou, Y. N. et al. FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: a longitudinal study. Alzheimers Res. Ther. 11, 57. https:\/\/doi.org\/10.1186\/s13195-019-0512-1 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"2039_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11682-012-9208-x","volume":"6","author":"C Habeck","year":"2012","unstructured":"Habeck, C. et al. Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer\u2019s disease. Brain Imaging Behav. 6, 568\u2013583. https:\/\/doi.org\/10.1007\/s11682-012-9208-x (2012).","journal-title":"Brain Imaging Behav."},{"key":"2039_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.arr.2016.02.003","volume":"30","author":"T Kato","year":"2016","unstructured":"Kato, T., Inui, Y., Nakamura, A. & Ito, K. Brain Fluorodeoxyglucose (FDG) PET in dementia. Ageing Res. Rev. 30, 73\u201384. https:\/\/doi.org\/10.1016\/j.arr.2016.02.003 (2016).","journal-title":"Ageing Res. Rev."},{"key":"2039_CR42","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","volume":"35","author":"DS Knopman","year":"2014","unstructured":"Knopman, D. S. et al. 18F-fluorodeoxyglucose positron emission tomography, aging, and Apolipoprotein E genotype in cognitively normal persons. Neurobiol. Aging. 35, 2096\u20132106. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.006 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2039_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/brain.2020.0937","volume":"13","author":"V Gupta","year":"2023","unstructured":"Gupta, V., Booth, S. & Ko, J. H. Hypermetabolic cerebellar connectome in Alzheimer\u2019s disease. Brain Connect. 13, 356\u2013366. https:\/\/doi.org\/10.1089\/brain.2020.0937 (2023).","journal-title":"Brain Connect."},{"key":"2039_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","volume":"35","author":"SC Johnson","year":"2014","unstructured":"Johnson, S. C. et al. Amyloid burden and neural function in people at risk for Alzheimer\u2019s disease. Neurobiol. Aging. 35, 576\u2013584. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.028 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2039_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hbm.22173","volume":"35","author":"H Oh","year":"2014","unstructured":"Oh, H., Habeck, C., Madison, C. & Jagust, W. Covarying alterations in A\u03b2 deposition, glucose metabolism, and Gray matter volume in cognitively normal elderly. Hum. Brain. Mapp. 35, 297\u2013308. https:\/\/doi.org\/10.1002\/hbm.22173 (2014).","journal-title":"Hum. Brain. Mapp."},{"key":"2039_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11357-023-01031-w","volume":"46","author":"A Bakhtiari","year":"2023","unstructured":"Bakhtiari, A. et al. Early cerebral amyloid-\u03b2 accumulation and hypermetabolism are associated with subtle cognitive deficits before accelerated cerebral atrophy. GeroScience 46, 769\u2013782. https:\/\/doi.org\/10.1007\/s11357-023-01031-w (2023).","journal-title":"GeroScience"},{"key":"2039_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JAD-150190","volume":"48","author":"N Kemppainen","year":"2015","unstructured":"Kemppainen, N. et al. Long-Term interrelationship between brain metabolism and amyloid deposition in mild cognitive impairment. J. Alzheimers Dis. 48, 123\u2013133. https:\/\/doi.org\/10.3233\/JAD-150190 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"2039_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","volume":"42","author":"A Ashraf","year":"2015","unstructured":"Ashraf, A., Fan, Z., Brooks, D. J. & Edison, P. Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur. J. Nucl. Med. Mol. Imaging. 42, 447\u2013458. https:\/\/doi.org\/10.1007\/s00259-014-2919-z (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2039_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41467-021-21057-y","volume":"12","author":"JM Roe","year":"2021","unstructured":"Roe, J. M. et al. Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer\u2019s disease. Nat. Commun. 12, 721. https:\/\/doi.org\/10.1038\/s41467-021-21057-y (2021).","journal-title":"Nat. Commun."},{"key":"2039_CR50","doi-asserted-by":"publisher","first-page":"fcab211","DOI":"10.1093\/braincomms\/fcab211","volume":"3","author":"N Lubben","year":"2021","unstructured":"Lubben, N., Ensink, E., Coetzee, G. A. & Labrie, V. The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases. Brain Commun. 3, fcab211. https:\/\/doi.org\/10.1093\/braincomms\/fcab211 (2021).","journal-title":"Brain Commun."},{"key":"2039_CR51","unstructured":"Costa, A. & Villalba, E. Horizons in Neuroscience Research (Nova Science Publishers, Inc, 2012)."},{"key":"2039_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/alz.12797","volume":"19","author":"MW Weiner","year":"2023","unstructured":"Weiner, M. W. et al. Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer\u2019s disease neuroimaging initiative 4. Alzheimer\u2019s Dement. 19, 307\u2013317. https:\/\/doi.org\/10.1002\/alz.12797 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2039_CR53","doi-asserted-by":"publisher","unstructured":"Mitchell, A. K. et al. Analysis of eligibility criteria in Alzheimer\u2019s and related dementias clinical trials. Sci. Rep. 14 https:\/\/doi.org\/10.1038\/s41598-024-65767-x (2024).","DOI":"10.1038\/s41598-024-65767-x"},{"key":"2039_CR54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.12120010","volume":"266","author":"JL Shaffer","year":"2013","unstructured":"Shaffer, J. L. et al. Predicting cognitive decline in subjects at risk for alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266, 583\u2013591. https:\/\/doi.org\/10.1148\/radiol.12120010 (2013).","journal-title":"Radiology"},{"key":"2039_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14, 535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2039_CR56","doi-asserted-by":"publisher","first-page":"195014","DOI":"10.1088\/1361-6560\/ac8f10","volume":"67","author":"A Deatsch","year":"2022","unstructured":"Deatsch, A., Perovnik, M., Nam\u00edas, M., Tro\u0161t, M. & Jeraj, R. Development of a deep learning network for Alzheimer\u2019s disease classification with evaluation of imaging modality and longitudinal data. Phys. Med. Biol. 67, 195014. https:\/\/doi.org\/10.1088\/1361-6560\/ac8f10 (2022).","journal-title":"Phys. Med. Biol."},{"key":"2039_CR57","doi-asserted-by":"publisher","first-page":"e1358","DOI":"10.1212\/WNL.0000000000011521","volume":"96","author":"G Blazhenets","year":"2021","unstructured":"Blazhenets, G. et al. Validation of the alzheimer disease dementia Conversion-Related pattern as an ATN biomarker of neurodegeneration. Neurology 96, e1358\u2013e1368. https:\/\/doi.org\/10.1212\/WNL.0000000000011521 (2021).","journal-title":"Neurology"},{"key":"2039_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","volume":"12","author":"PA Della Rosa","year":"2014","unstructured":"Della Rosa, P. A. et al. A standardized [18F]-FDG-PET template for Spatial normalization in statistical parametric mapping of dementia. Neuroinformatics (Totowa N J). 12, 575\u2013593. https:\/\/doi.org\/10.1007\/s12021-014-9235-4 (2014).","journal-title":"Neuroinformatics (Totowa N J)"},{"key":"2039_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","volume":"46","author":"A Joshi","year":"2009","unstructured":"Joshi, A., Koeppe, R. A. & Fessler, J. A. Reducing between scanner differences in multi-center PET studies. NeuroImage (Orlando Fla). 46, 154\u2013159. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.01.057 (2009).","journal-title":"NeuroImage (Orlando Fla)"},{"key":"2039_CR60","doi-asserted-by":"publisher","unstructured":"Huang, G., Liu, Z., van der Laurens, M. & Weinberger, K. Q. Densely Connected Convolutional Networks. arXiv.org, (2018). https:\/\/doi.org\/10.48550\/arxiv.1608.06993","DOI":"10.48550\/arxiv.1608.06993"},{"key":"2039_CR61","doi-asserted-by":"publisher","DOI":"10.48550\/arxiv.1603.05027","author":"K He","year":"2016","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Identity mappings in deep residual networks. ArXiv Org. https:\/\/doi.org\/10.48550\/arxiv.1603.05027 (2016).","journal-title":"ArXiv Org."},{"key":"2039_CR62","doi-asserted-by":"publisher","first-page":"108029","DOI":"10.1016\/j.compbiomed.2024.108029","volume":"170","author":"L Bloch","year":"2024","unstructured":"Bloch, L., Friedrich, C. M. & Initiative, A. s. D. N. Systematic comparison of 3D deep learning and classical machine learning explanations for Alzheimer\u2019s disease detection. Comput. Biol. Med. 170, 108029. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108029 (2024).","journal-title":"Comput. Biol. Med."},{"key":"2039_CR63","doi-asserted-by":"publisher","DOI":"10.48550\/arxiv.1607.08022","author":"D Ulyanov","year":"2017","unstructured":"Ulyanov, D., Vedaldi, A. & Lempitsky, V. Instance normalization: the missing ingredient for fast stylization. ArXiv Org. https:\/\/doi.org\/10.48550\/arxiv.1607.08022 (2017).","journal-title":"ArXiv Org."},{"key":"2039_CR64","doi-asserted-by":"publisher","unstructured":"Lin, M., Chen, Q. & Yan, S. Network in network. https:\/\/doi.org\/10.48550\/arxiv.1312.4400 (2013).","DOI":"10.48550\/arxiv.1312.4400"},{"key":"2039_CR65","doi-asserted-by":"publisher","DOI":"10.48550\/arxiv.1207.0580","author":"GE Hinton","year":"2012","unstructured":"Hinton, G. E., Srivastava, N., Krizhevsky, A., Sutskever, I. & Salakhutdinov, R. R. Improving neural networks by preventing co-adaptation of feature detectors. ArXiv Org. https:\/\/doi.org\/10.48550\/arxiv.1207.0580 (2012).","journal-title":"ArXiv Org."},{"key":"2039_CR66","doi-asserted-by":"publisher","DOI":"10.48550\/arxiv.1710.10686","author":"J Kuka\u010dka","year":"2017","unstructured":"Kuka\u010dka, J., Golkov, V. & Cremers, D. Regularization for deep learning: A taxonomy. ArXiv Org. https:\/\/doi.org\/10.48550\/arxiv.1710.10686 (2017).","journal-title":"ArXiv Org."},{"key":"2039_CR67","unstructured":"Springenberg, J. T., Dosovitskiy, A., Brox, T. & Riedmiller, M. Striving for simplicity: The all convolutional net. arXiv preprint arXiv:1412.6806 (2014)."},{"key":"2039_CR68","doi-asserted-by":"publisher","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls, E. T., Huang, C. C., Lin, C. P., Feng, J. & Joliot, M. Automated anatomical labelling atlas 3. Neuroimage 206, 116189 (2020).","journal-title":"Neuroimage"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02039-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:13:14Z","timestamp":1747465994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02039-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17187"}}